日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Randomized clinical efficacy and safety study of peltopepimut-S plus cemiplimab compared to cemiplimab alone in patients with recurrent/metastatic HPV16-positive head and neck cancer

一项随机临床疗效和安全性研究,比较了peltopepimut-S联合cemiplimab与单用cemiplimab治疗复发/转移性HPV16阳性头颈癌患者的疗效和安全性。

Even, Caroline; Harrington, Kevin J; Massarelli, Erminia; Laban, Simon; Fayette, Jérôme; Oliva, Marc; Klein Hesselink, Marielle; Visscher, Sonja; Fury, Matthew G; Wiekmeijer, Anna-Sophia; Licitra, Lisa; Melichar, Bohuslav; Devriese, Lot A; Braña, Irene; Jankowska, Petra; Posner, Marshall; Glisson, Bonnie; Kong, Anthony; Hooftman, Leon; Melief, Cornelis J M MD,; Ferrarotto, Renata

YAP1 Status Defines Two Intrinsic Subtypes of LCNEC with Distinct Molecular Features and Therapeutic Vulnerabilities.

YAP1 状态定义了 LCNEC 的两种内在亚型,它们具有不同的分子特征和治疗脆弱性

Stewart C Allison, Diao Lixia, Xi Yuanxin, Wang Runsheng, Ramkumar Kavya, Serrano Alejandra G, Tanimoto Azusa, Rodriguez B Leticia, Morris Benjamin B, Shen Li, Zhang Bingnan, Yang Yan, Hamad Samera H, Cardnell Robert J, Duarte Alberto Jr, Sahu Moushumi, Novegil Veronica Y, Weissman Bernard E, Frumovitz Michael, Kalhor Neda, Solis Soto Luisa, da Rocha Pedro, Vokes Natalie, Gibbons Don L, Wang Jing, Heymach John V, Glisson Bonnie, Byers Lauren Averett, Gay Carl M

Phase II Clinical Trial of Axitinib and Avelumab in Patients With Recurrent/Metastatic Adenoid Cystic Carcinoma

阿昔替尼联合阿维鲁单抗治疗复发/转移性腺样囊性癌患者的II期临床试验

Ferrarotto, Renata; Sousa, Luana G; Feng, Lei; Mott, Frank; Blumenschein, George; Altan, Mehmet; Bell, Diana; Bonini, Flavia; Li, Kaiyi; Marques-Piubelli, Mario L; Dal Lago, Eduardo A; Johnson, Jason J; Mitani, Yoshitsugu; Godoy, Myrna; Lee, Anna; Kupferman, Michael; Hanna, Ehab; Glisson, Bonnie S; Elamin, Yasir; El-Naggar, Adel

Human papillomavirus status and prognosis of oropharyngeal high-grade neuroendocrine carcinoma

人乳头瘤病毒感染状况与口咽高级别神经内分泌癌的预后

de Sousa, Luana G; Lazar Neto, Felippe; Dal Lago, Eduardo A; Sikora, Andrew; Hanna, Ehab; Moreno, Amy; Phan, Jack; Glisson, Bonnie S; Bell, Diana; Ferrarotto, Renata

ISA101 and nivolumab for HPV-16(+) cancer: updated clinical efficacy and immune correlates of response

ISA101 和纳武利尤单抗治疗 HPV-16(+) 癌症:最新临床疗效和免疫反应相关性

Sousa, Luana Guimaraes de; Rajapakshe, Kimal; Rodriguez Canales, Jaime; Chin, Renee L; Feng, Lei; Wang, Qi; Barrese, Tomas Z; Massarelli, Erminia; William, William; Johnson, Faye M; Ferrarotto, Renata; Wistuba, Ignacio; Coarfa, Cristian; Lee, Jack; Wang, Jing; Melief, Cornelis J M; Curran, Michael A; Glisson, Bonnie S

Evaluation of programmed death ligand 1 expression in cytology to determine eligibility for immune checkpoint inhibitor therapy in patients with head and neck squamous cell carcinoma

通过细胞学评估程序性死亡配体1(PD-L1)的表达,以确定头颈部鳞状细胞癌患者是否适合接受免疫检查点抑制剂治疗。

Liu, Zhonghua; Williams, Michelle; Stewart, John; Glisson, Bonnie S; Fuller, Clifton; Roy-Chowdhuri, Sinchita

Oncogene-specific differences in tumor mutational burden, PD-L1 expression, and outcomes from immunotherapy in non-small cell lung cancer

非小细胞肺癌中肿瘤突变负荷、PD-L1表达和免疫治疗结果的癌基因特异性差异

Negrao, Marcelo V; Skoulidis, Ferdinandos; Montesion, Meagan; Schulze, Katja; Bara, Ilze; Shen, Vincent; Xu, Hao; Hu, Sylvia; Sui, Dawen; Elamin, Yasir Y; Le, Xiuning; Goldberg, Michael E; Murugesan, Karthikeyan; Wu, Chang-Jiun; Zhang, Jianhua; Barreto, David S; Robichaux, Jacqulyne P; Reuben, Alexandre; Cascone, Tina; Gay, Carl M; Mitchell, Kyle G; Hong, Lingzhi; Rinsurongkawong, Waree; Roth, Jack A; Swisher, Stephen G; Lee, Jack; Tsao, Anne; Papadimitrakopoulou, Vassiliki; Gibbons, Don L; Glisson, Bonnie S; Singal, Gaurav; Miller, Vincent A; Alexander, Brian; Frampton, Garrett; Albacker, Lee A; Shames, David; Zhang, Jianjun; Heymach, John V

Proteogenomic Analysis of Salivary Adenoid Cystic Carcinomas Defines Molecular Subtypes and Identifies Therapeutic Targets

唾液腺腺样囊性癌的蛋白质基因组学分析定义了分子亚型并确定了治疗靶点

Ferrarotto, Renata; Mitani, Yoshitsugu; McGrail, Daniel J; Li, Kaiyi; Karpinets, Tatiana V; Bell, Diana; Frank, Steven J; Song, Xingzhi; Kupferman, Michael E; Liu, Bin; Lee, J Jack; Glisson, Bonnie S; Zhang, Jianhua; Aster, Jon C; Lin, Shiaw-Yih; Futreal, P Andrew; Heymach, John V; El-Naggar, Adel K

Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck

局部晚期可切除头颈部皮肤鳞状细胞癌新辅助免疫疗法的II期试点试验

Ferrarotto, Renata; Amit, Moran; Nagarajan, Priyadharsini; Rubin, M Laura; Yuan, Ying; Bell, Diana; El-Naggar, Adel K; Johnson, Jason M; Morrison, William H; Rosenthal, David I; Glisson, Bonnie S; Johnson, Faye M; Lu, Charles; Mott, Frank E; Esmaeli, Bita; Diaz, Eduardo M Jr; Gidley, Paul W; Goepfert, Ryan P; Lewis, Carol M; Weber, Randal S; Wargo, Jennifer A; Basu, Sreyashi; Duan, Fei; Yadav, Shalini S; Sharma, Padmanee; Allison, James P; Myers, Jeffrey N; Gross, Neil D

Integrating depth of invasion in T classification improves the prognostic performance of the American Joint Committee on Cancer primary tumor staging system for cutaneous squamous cell carcinoma of the head and neck

将浸润深度纳入T分期可提高美国癌症联合委员会(AJCC)原发肿瘤分期系统对头颈部皮肤鳞状细胞癌的预后预测性能。

Amit, Moran; Liu, Chuan; Netto Gleber, Frederico-Omar; Kini, Sameer; Tam, Samantha; Benov, Avi; Aashiq, Mohamed; El-Naggar, Adel K; Moreno, Amy C; Rosenthal, David I; Glisson, Bonnie S; Ferrarotto, Renata; Wong, Michael K; Migden, Michael R; Li, Guojun; Khanna, Anshu; Goepfert, Ryan P; Nagarajan, Priyadharsini; Weber, Randal S; Myers, Jeffrey N; Gross, Neil D